FS Research highly evaluated Genomictree's growth potential in a report on the 8th. Genomictree is a company that discovers biomarkers, verifies clinical efficacy, and develops and sells early diagnosis products for various cancers (colonial cancer, lung cancer, bladder cancer, etc.).

According to the report, sales of Genomictree's colorectal cancer diagnostic kits are soaring in Korea. Sales of colon cancer diagnostic kits, which recorded 300 million won last year, are estimated to be about 900 million won in the first half of this year, with 3 billion won annually.

Hwang Se-hwan, a researcher at FS Research, said, "Genomictree's diagnostic kit is much simpler than colonoscopy because it